BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18651349)

  • 21. Lithium intoxication after valsartan treatment.
    Su YP; Chang CJ; Hwang TJ
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):204. PubMed ID: 17362443
    [No Abstract]   [Full Text] [Related]  

  • 22. Prophylaxis of bipolar disorder: how and who should we treat in the long term?
    Goodwin GM
    Eur Neuropsychopharmacol; 1999 Aug; 9 Suppl 4():S125-9. PubMed ID: 10524839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical decision making in the treatment of mania.
    Perlis RH
    J Clin Psychiatry; 2008; 69 Suppl 5():16-21. PubMed ID: 19265636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid intoxication in a patient with bipolar disorder and chronic uremia.
    Lapierre O; Dubreucq JL; Beauchemin MA; Vinet B
    Can J Psychiatry; 1999 Mar; 44(2):188. PubMed ID: 10097841
    [No Abstract]   [Full Text] [Related]  

  • 25. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
    Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
    Wheeler A; Robinson G; Fraser A
    Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium toxicity presenting as delirium in an older patient.
    Wilkinson A; Gavine A; Black K
    Practitioner; 2009 May; 253(1718):28-30. PubMed ID: 19517683
    [No Abstract]   [Full Text] [Related]  

  • 28. Cerebellar atrophy after long-term treatment with low-dose lithium.
    Fischera M; Anneken K; Evers S; Kloska S; Husstedt IW
    Pharmacopsychiatry; 2009 May; 42(3):125-6. PubMed ID: 19452383
    [No Abstract]   [Full Text] [Related]  

  • 29. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.
    Licht RW; Gijsman H; Nolen WA; Angst J
    Acta Psychiatr Scand; 2008 Nov; 118(5):337-46. PubMed ID: 18754834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lithium, a potentially dangerous drug].
    Liem KS
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):1017-8; author reply 1018-9. PubMed ID: 15903046
    [No Abstract]   [Full Text] [Related]  

  • 31. Thyrotoxicosis: an under-recognised aetiology.
    Dave A; Ludlow J; Malaty J
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25994428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis.
    Knijff EM; Kupka RW; Ruwhof C; Breunis MN; Prens EP; Nolen WA; Drexhage HA
    Bipolar Disord; 2005 Aug; 7(4):388-9. PubMed ID: 16026493
    [No Abstract]   [Full Text] [Related]  

  • 33. Contrast-induced thyrotoxicosis.
    Kulstad CE; Carlson A
    Ann Emerg Med; 2004 Sep; 44(3):281-2. PubMed ID: 15332308
    [No Abstract]   [Full Text] [Related]  

  • 34. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
    Kauer-Sant'Anna M; Bond DJ; Lam RW; Yatham LN
    Compr Psychiatry; 2009; 50(1):1-8. PubMed ID: 19059506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lithium, a potentially dangerous drug].
    Monnens LA; Levtchenko E
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):1019; author reply 1019. PubMed ID: 15903049
    [No Abstract]   [Full Text] [Related]  

  • 37. The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): one-year follow-up of a single case.
    Porto FH; Leite MA; Fontenelle LF; Marrocos RP; Szczerback NF; de Freitas MR
    J Neurol Sci; 2009 Feb; 277(1-2):172-3. PubMed ID: 19046589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
    Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K
    Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term lithium therapy leading to hyperparathyroidism: a case report.
    Rizwan MM; Perrier ND
    Perspect Psychiatr Care; 2009 Jan; 45(1):62-5. PubMed ID: 19154241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.